When progression to the overt MM stage occurs, the integral immune profiling of the MM microenvironment is characterized by an increase in NK, T, and CD16+ cells, as well as a decrease in plasmacytoid DCs, immature neutrophils, CD14+ monocytes, and other progenitor cells. The gene discussed is CD14; the disease is Miyoshi myopathy.